| Literature DB >> 34220002 |
Mohd A Ganie1, Fouzia Rashid2, Saika Manzoor2, Sabhiya Majid3, Iram Shabir3, Iram A Kawa2, Qudsia Fatima2, Humira Jeelani2, Syed Douhath Yousuf2.
Abstract
Human polycystic ovary syndrome (PCOS)-a cluster of diseases displays various symptoms associated with endocrine and gynecological disorders in childbearing women. Oral contraceptive pills (OCP) being a drug of choice minimizes symptoms and complications associated with the disorder. But, the controversial data available in literature regarding use of OCPs compels us to setup a study design regarding effect of OCP treatment in PCOS subjects and the possible outcomes specifically regarding coagulation pathways. Two PCOS study groups have been selected according to Rotterdam Criteria: one with OCP treatment (n = 50) and other without any drug treatment i.e., drug naive (n = 50). Anthropometry, Biochemistry, Hormones, Insulin and various clotting factors like Factor XI, Factor V, tPA, TAT-III and D-dimer were analyzed in both groups. The results showed worsening of IR, Metabolic parameters and coagulopathy in OCP group comparative to drug naive group indicating adverse effects of the OCP treatment which puts these women at risk for number of future clinical implications especially Cardiovascular and metabolic complications. © Association of Clinical Biochemists of India 2020.Entities:
Keywords: Coagulation pathway; Hyper-coagulability; Insulin resistance; OCP’s; Polycystic ovary syndrome
Year: 2020 PMID: 34220002 PMCID: PMC8215022 DOI: 10.1007/s12291-020-00901-w
Source DB: PubMed Journal: Indian J Clin Biochem ISSN: 0970-1915